Drug Type TCR-T Cell therapy  | 
Synonyms GB30103  | 
Target  | 
Action inhibitors  | 
Mechanism KRAS G13D inhibitors(KRAS G13D inhibitors), Gene transference(Gene transference), T lymphocyte replacements  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseDiscontinuedPreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Pancreatic Cancer | Preclinical | China   | 13 Feb 2023 | 





